Amiodarone-induced thyrotoxicosis

被引：6

作者：

Schubert, Louis ^{[1
]}

Bricaire, Leopoldine ^{[1
]}

Groussin, Lionel ^{[1
,2
,3
]}

机构：

[1] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France

[2] Univ Paris, F-75014 Paris, France

[3] Inst Cochin, Inserm Unite 1016, CNRS UMR 8104, F-75014 Paris, France

来源：

ANNALES D ENDOCRINOLOGIE | 2021年 / 82卷 / 3-4期

关键词：

Amiodarone; Thyrotoxicosis; Hyperthyroidism; ASSOCIATION; GUIDELINES; MANAGEMENT; TYPE-2; THYROIDECTOMY; CONTINUATION; THERAPY;

D O I：

10.1016/j.ando.2020.04.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians are sometimes faced with difficult diagnostic and therapeutic situations. The disease pathophysiology is partially understood, explaining the lack of predictive factors for occurrence. Different international recommendations for their management have been published: the most recent in 2018 by the European Thyroid Association (ETA) (Ross et al., 2016; Bartalena et al., 2018). The purpose of this paper is to present the essential concepts for their management and to review the literature since 2018. (C) 2020 Elsevier Masson SAS. All rights reserved.

引用

页码：163 / 166

页数：4

共 50 条

[41] Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan
Sato, K
Miyakawa, M
Eto, M
Inaba, T
Matsuda, N
Shiga, T
Ohnishi, S
Kasanuki, H
ENDOCRINE JOURNAL, 1999, 46 (03) : 443 - 451
[42] Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism
Hofmann, Andrea
Nawara, Clemens
Ofluoglu, Sedat
Holzmannhofer, Johannes
Strohmer, Bernhard
Pirich, Christian
WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (15-16) : 493 - 498
[43] A case of type 2 amiodarone-induced thyrotoxicosis
Soloviuk, O. A.
Kulynych, R. L.
Soloviuk, O. O.
ZAPOROZHYE MEDICAL JOURNAL, 2024, 26 (03) : 254 - 257
[44] Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
Ylli, Dorina
Wartofsky, Leonard
Burman, Kenneth D.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01) : 226 - 236
[45] Thyroid hormones and proinflammatory cytokines' profile in amiodarone-induced thyrotoxicosis
Trifanescu, Raluca
Fica, Siniona
Dimuleselt, Doina
Barbit, Carmen
Sirbu, Anca
Rotaru, Mihaela
Florea, Suzana
Purice, Mariana
Coculescu, M.
ACTA ENDOCRINOLOGICA-BUCHAREST, 2007, 3 (04) : 417 - 435
[46] Radioiodine therapy in patients with type II amiodarone-induced thyrotoxicosis
Czarnywojtek, Agata
Warmuz-Stangierska, Izabela
Wolinski, Kosma
Plazinska, Maria
Kobylecka, Malgorzata
Kunikowska, Jolanta
Stangierski, Adam
Miechowicz, Izabela
Waligorska-Stachura, Joanna
Rewers, Amanda
Krolicki, Leszek
Ruchala, Marek
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2014, 124 (12): : 695 - 703
[47] Amiodarone-induced thyrotoxicosis due to destructive thyroiditis - Therapeutic recommendations
Dietlein, M
Schicha, H
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (03) : 145 - 151
[48] An Audit of Amiodarone-induced Thyrotoxicosis - do Anti-thyroid Drugs alone Provide Adequate Treatment?
Patel, Nadia
Inder, Warrick J.
Sullivan, Clair
Kaye, Gerald
HEART LUNG AND CIRCULATION, 2014, 23 (06) : 549 - 554
[49] Real-life Data on the Effect of Medical Therapy for Amiodarone-induced Thyrotoxicosis on CV Events and Hospitalizations
Cappellani, Daniele
Marconcini, Giulia
Manetti, Luca
Bartalena, Luigi
Bogazzi, Fausto
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (06) : 1298 - 1307
[50] Amiodarone-Induced Thyrotoxicosis Is a Predictor of Adverse Cardiovascular Outcome
Yiu, Kai-Hang
Jim, Man-Hong
Siu, Chung-Wah
Lee, Chi-Ho
Yuen, Michele
Mok, Maggie
Shea, Yet-Fung
Fan, Katherine
Tse, Hung-Fat
Chow, Wing-Hing
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) : 109 - 114

← 1 2 3 4 5 →